Close Menu

sequencing-based diagnostics

NEW YORK (GenomeWeb News) – Coventry Health Care National Network has terminated its coverage agreement with Sequenom covering the MaterniT21 Plus test, just one week after the agreement was announced, the San Diego-based molecular diagnostics firm said after the close of the market on Thursday.

NEW YORK (GenomeWeb News) – Sequenom today said that health insurance provider Coventry Health Care National Network will provide coverage for its T21 test.

NEW YORK (GenomeWeb News) – Belgian molecular diagnostic company Multiplicom today announced a deal with French institutes ICM and ICAN to develop molecular diagnostic tests for the identification of genetic mutations associated with cardiovascular, metabolic, and neurological diseases.

NEW YORK (GenomeWeb News) – Ariosa Diagnostics today announced a partnership with Laboratory Corporation of America and Integrated Genetics to make its T21 test available in the US and Canada.

NEW YORK (GenomeWeb News) – Sequenom reported after the close of the market Thursday that its first-quarter revenues grew 10 percent year over year, driven by a sharp uptick in diagnostic services that was somewhat offset by a decline in genetic analysis product sales and services.

NEW YORK (GenomeWeb News) – As part of a global launch of its hospital-acquired infection kit, Pathogenica today announced a deal with Life Technologies Japan to distribute the kit in Japan on the Ion Torrent platform.

NEW YORK (GenomeWeb News) – Sequenom today said that it has extended the term of its supply agreement with Illumina from three to five years.

NEW YORK (GenomeWeb News) – Cancer molecular diagnostics firm MolecularMD announced today it has raised $6 million in a Series B equity financing round.

Pages

A study of families explores how children transmit SARS-CoV-2, according to the Associated Press.

US Agricultural Research Service scientists have sequenced the genome of the Asian giant hornet.

According to the Economist, pooled testing for COVID-19 could help alleviate strains on testing labs.

In Science this week: MIT researchers outline approach dubbed translatable components regression to predict treatment response among IBD patients.